Premium
AlloVir Inc (ALVR)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 9.81 | 9.81 | 9.81 | 0 | 0 | CS |
| 4 | -0.02 | -0.203458799593 | 9.83 | 10.35 | 9 | 6198 | 9.57858525 | CS |
| 12 | -0.77 | -7.27788279773 | 10.58 | 11.96 | 7.96 | 111633 | 9.56189925 | CS |
| 26 | -7.555 | -43.5070544198 | 17.365 | 24.15 | 7.96 | 245000 | 13.99028473 | CS |
| 52 | -7.67 | -43.8787185355 | 17.48 | 24.15 | 7.96 | 270844 | 15.96856927 | CS |
| 156 | -164.99 | -94.3878718535 | 174.8 | 236.67 | 7.96 | 678598 | 72.93307099 | CS |
| 260 | -515.05 | -98.1309301528 | 524.86 | 1126.08 | 7.96 | 537550 | 167.27742372 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
![Logo de Plian [PCHAIN] (PAIBTC).](/common/images/company/COIN_PAIUSD.png){kind=small}
